DrugDashboards

Azilsartan medoxomil

Azilsartan medoxomil · AZILSARTAN KAMEDOXOMIL 80 mg/1 · Tablet · Oral · Lupin Pharmaceuticals, Inc.

NDC 70748-0237-06 · 30 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA214489
TE code
AB
Approval date
Jul 20, 2022
Patents / exclusivity
0 patents, 2 exclusivities
TypeNumber / codeExpires
exclusivityPCDec 12, 2026
exclusivityPCDec 12, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Azilsartan medoxomil (Tablet)

LabelerStrengthFirst seenLast seen
Lupin Pharmaceuticals, Inc.AZILSARTAN KAMEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.AZILSARTAN KAMEDOXOMIL 80 mg/1Jul 15, 2026Sep 2, 2026
Takeda Ireland LimitedAZILSARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Takeda Ireland LimitedAZILSARTAN MEDOXOMIL 80 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Azilsartan medoxomil — NDC 70748-0237-06," retrieved September 3, 2026, https://drugdashboards.com/drug/70748023706.

Free to cite with attribution — see how the data is put together.